Rocket Pharmaceuticals shares are trading lower. The company announced the FDA issued a Complete Response Letter for the License Application For KRESLADI and requested limited additional Chemistry Manufacturing and Controls information to complete...
Rocket Pharmaceuticals, Inc. +2.64% Pre
Rocket Pharmaceuticals, Inc. RCKT | 17.49 17.49 | +2.64% 0.00% Pre |
Rocket Pharmaceuticals shares are trading lower. The company announced the FDA issued a Complete Response Letter for the License Application For KRESLADI and requested limited additional Chemistry Manufacturing and Controls information to complete its review.